Status:
TERMINATED
Continuous Glucose Monitoring Initiation at Hospital Discharge
Lead Sponsor:
Washington University School of Medicine
Conditions:
Type 1 Diabetes
Type2 Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to look at feasibility (the likelihood) of continued use of the FreeStyle Libre 2 Continuous glucose monitor (CGM) when started at the time of hospital discharge in patien...
Detailed Description
VISIT/PHONE CALL WHAT WILL HAPPEN? (estimated time) \[window\] Screening Visit (\~45 minutes) Review consent form and obtain consent Complete questionnaire, obtain diabetes history Day of Discharge (...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Have diabetes (type 1 diabetes mellitus, type 2 diabetes mellitus, cystic fibrosis related diabetes mellitus)
- Hemoglobin A1c greater than or equal to 8.0% or history of hypoglycemia unawareness
- Able and willing to sign informed consent form
- Have a valid telephone number
- Willing to purchase FreeStyle Libre 2 CGM sensors out of pocket after discharge from hospital (when insurance coverage isn't available)
Exclusion
- Unable to sign informed consent form
- Have altered mental status
- Unable to manage diabetes independently at home
- Have utilized CGM in the past
- Pregnancy
- New steroid-induced hyperglycemia
- Unwilling to participate in the study
- Have kidney disease requiring hemodialysis
- Taking high doses of vitamin C daily (greater than 500 mg every day)
Key Trial Info
Start Date :
April 13 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 13 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04854135
Start Date
April 13 2021
End Date
June 13 2022
Last Update
February 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barnes Jewish Hospital/ Washington University
St Louis, Missouri, United States, 63110